Literature DB >> 9618243

Endotoxin and tumor necrosis factor alpha exert a similar proinflammatory effect in neonatal rat cardiomyocytes, but have different cardiodepressant profiles.

U Müller-Werdan1, H Schumann, H Loppnow, R Fuchs, D Darmer, J Stadler, J Holtz, K Werdan.   

Abstract

Bolus application of endotoxin to healthy volunteers results in reversible hemodynamic alterations, such as observed in septic cardiomyopathy. Currently, endotoxin-induced cardiodepression is mainly attributed to the endotoxin-induced release of proinflammatory cytokines into the circulation, particularly of tumor necrosis factor alpha and interleukin-1, the serum levels of these cytokines being enhanced in sepsis and septic shock, and also in various heart diseases. In this study, we report a proinflammatory effect of endotoxin (1-10 micrograms/ml, 24-h incubation period) on neonatal rat cardiomyocytes in serum-free culture, evidenced by induction of inducible nitric oxide synthase, enhanced release of nitrite (protein synthesis-dependent) and interleukin-6 into the supernatant, as well as an increase in cell-associated interleukin-1 and a specific cardiodepressant profile: endotoxin disrupts beta-adrenoceptor-mediated increase in pulsation amplitude, but alpha-adrenoceptor-induced increase in pulsation amplitude and arrhythmias are not suppressed. In the presence of dexamethasone (0.1 microM), the endotoxin-mediated blockade of beta-adrenergic responsiveness, as well as induction of inducible nitric oxide synthase, enhanced nitrite release and interleukin-1/-6-production are inhibited. In contrast, tumor necrosis factor alpha at a low concentration (10 U/ml) depresses alpha- and beta-adrenergic responsiveness in the presence of dexamethasone in a nitric oxide-independent manner. These data suggest a stimulatory effect of endotoxin on the cardiomyocyte and a specific proinflammatory and nitric oxide-dependent cardiodepressant profile of endotoxin.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9618243     DOI: 10.1006/jmcc.1998.0667

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  13 in total

1.  Drug-disease interactions: reduced beta-adrenergic and potassium channel antagonist activities of sotalol in the presence of acute and chronic inflammatory conditions in the rat.

Authors:  K M Kulmatycki; K Abouchehade; S Sattari; F Jamali
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

2.  Heart rate as an independent risk factor in patients with multiple organ dysfunction: a prospective, observational study.

Authors:  Robert S Hoke; Ursula Müller-Werdan; Christine Lautenschläger; Karl Werdan; Henning Ebelt
Journal:  Clin Res Cardiol       Date:  2011-11-03       Impact factor: 5.460

3.  Targeted gene silencing of tumor necrosis factor attenuates the negative inotropic effects of lipopolysaccharide in isolated contracting cardiac myocytes.

Authors:  R S Ramabadran; Amanda Chancey; Jesus G Vallejo; Philip M Barger; Natarajan Sivasubramanian; Douglas L Mann
Journal:  Tex Heart Inst J       Date:  2008

4.  Acute myocardial infarction and cardiogenic shock: prognostic impact of cytokines: INF-γ, TNF-α, MIP-1β, G-CSF, and MCP-1β.

Authors:  R Prondzinsky; S Unverzagt; H Lemm; N Wegener; K Heinroth; U Buerke; M Fiedler; J Thiery; J Haerting; K Werdan; M Buerke
Journal:  Med Klin Intensivmed Notfmed       Date:  2012-07-20       Impact factor: 0.840

5.  Interleukin-1beta mediates endotoxin- and tumor necrosis factor alpha-induced RGS16 protein expression in cultured cardiac myocytes.

Authors:  Monica Patten; Sabine Stübe; Bryan Thoma; Thomas Wieland
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-10-18       Impact factor: 3.000

6.  Activation of AP-1 contributes to the beta-adrenoceptor-mediated myocardial induction of interleukin-6.

Authors:  Susanne Rohrbach; Stefan Engelhardt; Martin J Lohse; Karl Werdan; Juergen Holtz; Ursula Muller-Werdan
Journal:  Mol Med       Date:  2007 Nov-Dec       Impact factor: 6.354

7.  Altered interleukin-1 receptor antagonist and interleukin-18 mRNA expression in myocardial tissues of patients with dilatated cardiomyopathy.

Authors:  Elena Westphal; Susanne Rohrbach; Michael Buerke; Hagen Behr; Dorothea Darmer; Rolf-Edgar Silber; Karl Werdan; Harald Loppnow
Journal:  Mol Med       Date:  2008 Jan-Feb       Impact factor: 6.354

8.  Septic cardiomyopathy - A not yet discovered cardiomyopathy?

Authors:  Ursula Muller-Werdan; Michael Buerke; Henning Ebelt; Konstantin M Heinroth; Anja Herklotz; Harald Loppnow; Martin Ruß; Frithjof Schlegel; Axel Schlitt; Hendrik B Schmidt; Gerold Söffker; Karl Werdan
Journal:  Exp Clin Cardiol       Date:  2006

Review 9.  Proinflammatory Cytokines Mediate GPCR Dysfunction.

Authors:  Maradumane L Mohan; Neelakantan T Vasudevan; Sathyamangla V Naga Prasad
Journal:  J Cardiovasc Pharmacol       Date:  2017-08       Impact factor: 3.105

10.  Myocardial dysfunction in sepsis: a large, unsolved puzzle.

Authors:  Constantino Jose Fernandes; Murillo Santucci Cesar de Assuncao
Journal:  Crit Care Res Pract       Date:  2012-03-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.